The global Irritable Bowel Syndrome Treatment Drug market was valued at 3399 million in 2024 and is projected to reach US$ 4259 million by 2031, at a CAGR of 3.4% during the forecast period.
Irritable bowel syndrome (IBS) is a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It\"s usually a lifelong problem.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Irritable Bowel Syndrome Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment Drug. This report contains market size and forecasts of Irritable Bowel Syndrome Treatment Drug in global, including the following market information:
Global Irritable Bowel Syndrome Treatment Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Irritable Bowel Syndrome Treatment Drug companies in 2024 (%)
Total Market by Segment:
Global Irritable Bowel Syndrome Treatment Drug market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug market segment percentages, by Type, 2024 (%)
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others
Global Irritable Bowel Syndrome Treatment Drug market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug market segment percentages, by Application, 2024 (%)
Hospitals
Specialty Clinics
Other
Global Irritable Bowel Syndrome Treatment Drug market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome Treatment Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome Treatment Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome Treatment Drug, market overview.
Chapter 2: Global Irritable Bowel Syndrome Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Irritable Bowel Syndrome Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome Treatment Drug Overall Market Size
2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size: 2024 VS 2031
2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome Treatment Drug Players in Global Market
3.2 Top Global Irritable Bowel Syndrome Treatment Drug Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome Treatment Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Irritable Bowel Syndrome Treatment Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Irritable Bowel Syndrome Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Irritable Bowel Syndrome Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Market Size Markets, 2024 & 2031
4.1.2 Antibiotics
4.1.3 Amino Salicylates
4.1.4 Corticosteroids
4.1.5 Immunomodulators
4.1.6 Others
4.2 Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Market Size, 2024 & 2031
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Other
5.2 Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome Treatment Drug Market Size, 2024 & 2031
6.2 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2025
6.2.2 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2026-2031
6.2.3 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2031
6.3.2 United States Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.3.3 Canada Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.3.4 Mexico Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2031
6.4.2 Germany Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.3 France Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.4 U.K. Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.5 Italy Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.6 Russia Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.7 Nordic Countries Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.4.8 Benelux Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2031
6.5.2 China Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.5.3 Japan Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.5.4 South Korea Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.5.5 Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.5.6 India Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2031
6.6.2 Brazil Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.6.3 Argentina Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, 2020-2031
6.7.2 Turkey Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.7.3 Israel Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.7.4 Saudi Arabia Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
6.7.5 UAE Irritable Bowel Syndrome Treatment Drug Market Size, 2020-2031
7 Companies Profiles
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Corporate Summary
7.1.2 Abbvie Inc. Business Overview
7.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.1.4 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.1.5 Abbvie Inc. Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Corporate Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.2.4 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.3.4 Roche Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.3.5 Roche Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.4.4 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.5.4 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.5.5 Pfizer Inc. Key News & Latest Developments
7.6 Prometheus Laboratories Inc. (Nestle)
7.6.1 Prometheus Laboratories Inc. (Nestle) Corporate Summary
7.6.2 Prometheus Laboratories Inc. (Nestle) Business Overview
7.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.6.4 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.6.5 Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
7.7 Bausch Health
7.7.1 Bausch Health Corporate Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.7.4 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.7.5 Bausch Health Key News & Latest Developments
7.8 Takeda Pharmaceutical Ltd
7.8.1 Takeda Pharmaceutical Ltd Corporate Summary
7.8.2 Takeda Pharmaceutical Ltd Business Overview
7.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.8.4 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.8.5 Takeda Pharmaceutical Ltd Key News & Latest Developments
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.9.4 Biogen Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.9.5 Biogen Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.10.4 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2020-2025)
7.10.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Irritable Bowel Syndrome Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Irritable Bowel Syndrome Treatment Drug Market Drivers in Global Market
Table 3. Irritable Bowel Syndrome Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Irritable Bowel Syndrome Treatment Drug in Global Market
Table 5. Top Irritable Bowel Syndrome Treatment Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Irritable Bowel Syndrome Treatment Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Irritable Bowel Syndrome Treatment Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Irritable Bowel Syndrome Treatment Drug Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome Treatment Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Treatment Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2026-2031
Table 30. Abbvie Inc. Corporate Summary
Table 31. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 32. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Abbvie Inc. Key News & Latest Developments
Table 34. Bristol Myers Squibb Corporate Summary
Table 35. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 36. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Bristol Myers Squibb Key News & Latest Developments
Table 38. Roche Corporate Summary
Table 39. Roche Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 40. Roche Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 41. Roche Key News & Latest Developments
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 44. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Inc. Corporate Summary
Table 47. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 48. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Prometheus Laboratories Inc. (Nestle) Corporate Summary
Table 51. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 52. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
Table 54. Bausch Health Corporate Summary
Table 55. Bausch Health Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 56. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Bausch Health Key News & Latest Developments
Table 58. Takeda Pharmaceutical Ltd Corporate Summary
Table 59. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 60. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Takeda Pharmaceutical Ltd Key News & Latest Developments
Table 62. Biogen Corporate Summary
Table 63. Biogen Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 64. Biogen Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Biogen Key News & Latest Developments
Table 66. AstraZeneca Corporate Summary
Table 67. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 68. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 69. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome Treatment Drug Product Picture
Figure 2. Irritable Bowel Syndrome Treatment Drug Segment by Type in 2024
Figure 3. Irritable Bowel Syndrome Treatment Drug Segment by Application in 2024
Figure 4. Global Irritable Bowel Syndrome Treatment Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Irritable Bowel Syndrome Treatment Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Irritable Bowel Syndrome Treatment Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome Treatment Drug Revenue in 2024
Figure 9. Segmentation by Type – Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 13. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 14. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 15. United States Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 19. Germany Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 20. France Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 27. China Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 31. India Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 33. Brazil Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2020-2031
Figure 36. Turkey Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2020-2031
Figure 40. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Roche Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Biogen Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
